期刊文献+

胃蛋白酶原联合多种肿瘤标志物检测在胃癌早期诊断中的价值 被引量:44

The value of pepsinogen combined with multiple tumor markers detection in the early diagnosis of gastric cancer
下载PDF
导出
摘要 目的:探讨胃蛋白酶原(PGⅠ、PGⅠ/PGⅡ)联合糖类抗原CA199、糖蛋白抗原CA125、糖脂类抗原CA242、糖类抗原CA724、癌胚抗原CEA检测在胃癌早期诊断中的价值。方法:检测80例胃癌患者血清(均经胃镜取材,病理活检确诊)、60例胃良性病变患者血清(经胃镜确诊的浅表性胃炎、萎缩性胃炎、胃十二指肠溃疡等)、100例健康人群血清(作为正常对照组),比较三组间的数值变化以及单一检测和联合检测敏感度、特异度的差异。结果:胃癌组和胃良性病变组及健康对照组之间,肿瘤标志物PGⅠ、PGⅠ/PGⅡ和CA199、CA125、CA724、CA242及CEA检测水平均有统计学差异(P<0.05)。较各单一指标检测,胃蛋白酶原及多肿瘤标志物联合检测敏感度为85.6%,明显增高,差异均有统计学意义(P<0.05)。结论:肿瘤标志物PGⅠ、PGⅠ/PGⅡ比值、CA199、CA125、CA724、CA242及CEA单一检测对胃癌的诊断均有一定价值,7者联合检测更能提高胃癌早期的诊断率。 Objective:To explore the value of pepsinogen(PGⅠ,PGⅠ/PGⅡ) combined with carbohydrate antigen CA199,glycoprotein antigen CA125,glycolipid antigen CA242,carbohydrate antigen CA724,carcinoembryonic antigen CEA in early diagnosis of gastric cancer.Methods:The serum of 80 cases of gastric cancer patients(all confirmed by gastroscopy,pathological biopsy),60 cases of benign gastric lesions(superficial gastritis,atrophic gastritis,gastroduodenal ulcer,etc,confirmed by gastroscopy),100 cases of health persons(as a normal control group) were used to compared the numerical changes in the three groups and the differences in sensitivity and specificity between single detection and combined detection.Results:There were statistically significant differences in the level of tumor markers PGⅠ,PGⅠ/PGⅡ and CA199,CA125,CA724,CA242 and CEA levels in the three groups(P〈0.05).Compared with the single index detection,the sensitivity of combined detection was 85.6%,the differences were statistically significant(P〈0.05).Conclusion:The single detection of PGⅠ,PGⅠ/PGⅡ ratio,CA199,CA125,CA724,CA242 and CEA for the diagnosis of gastric cancer have a certain value,and and the combined detection of above seven tumor makers could improve the early diagnosis rate of gastric cancer.
出处 《现代肿瘤医学》 CAS 2017年第16期2622-2625,共4页 Journal of Modern Oncology
关键词 胃癌 胃蛋白酶原 肿瘤标志物 gastric cancer pepsinogen tumor marker
  • 相关文献

参考文献2

二级参考文献30

  • 1Ministry of Health. National death survey report,2004-2005[M].Beijing:Peking Union Medical College Publication House,2008. 被引量:1
  • 2Lu FZ,Zhang SW,Chen YH. Investigation analysis of cancer registration in China[J].Zhong Guo Zhong Liu,2004.134-41. 被引量:1
  • 3Chen WQ,Zhao P,Rao KQ. A primary cancer registration system in China,2010[J].Zhonghua Yufang Yixue Zazhi,2010.374-5. 被引量:1
  • 4National Office for Cancer Prevention and Control.China cancer annual report,2010[M]北京:军事医学科学出版社,2011. 被引量:1
  • 5Curado MP,Edwards B,Shin HR. Cancer Incidence in Five Continents,Vol.Ⅸ[A].Lyon:iarc Press,2007. 被引量:1
  • 6Parkin DM,Chen VW,Ferlay J. Comparability and quality control in cancer registration.[=IARC Technical Report No.19,][R].Lyon:iarc Press,1994. 被引量:1
  • 7Felay J,Burkhard C,Whelan S. Check and conversion programs for cancer registries.[IARC Technical Report No.42.][R].Lyon:iarc Press,2005. 被引量:1
  • 8Chen WQ,Zhang SW,Zou XN. Cancer incidence and mortality in China,2006[J].Chinese Journal of Cancer Research,2011.3-9. 被引量:1
  • 9Chen WQ,Zheng RS,Zeng HM. Bayesian age-period-cohort prediction of lung cancer incidence in China[J].Thoracic Cancer,2011.149-55. 被引量:1
  • 10Shopland DR,Eyre H J,Pechacek TF. Smoking-attributable cancer mortality in,1991:is lung cancer now the leading cause of death among smokers in the United States[J].Journal of the National Cancer Institute,1991.1142-8. 被引量:1

共引文献98

同被引文献413

引证文献44

二级引证文献272

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部